HCCI

ALERT: The M&A Class Action Firm Continues Investigating the Merger – NXGN, HCCI, AMNB, AVTA

Retrieved on: 
Thursday, September 28, 2023

Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.
  • Under the terms of the agreement, AVTA shareholders are expected to receive $26.00 in cash per share they own.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DBTX, RETA, VRTV, HCCI

Retrieved on: 
Monday, September 18, 2023

Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash plus one non-tradeable CVR worth up to $3.50 per share they own.

Key Points: 
  • Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash plus one non-tradeable CVR worth up to $3.50 per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, RETA shareholders are expected to receive $172.50 in cash per share they own.
  • Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – VRTV, HCCI, RETA, ACER

Retrieved on: 
Tuesday, September 12, 2023

Under the terms of the agreement, VRTV shareholders will receive $170.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, VRTV shareholders will receive $170.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.
  • Acer Therapeutics, Inc. (Nasdaq: ACER ), relating to its proposed merger with Zevra Therapeutics, Inc.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – HCCI, CEQP, CELL, CTG

Retrieved on: 
Wednesday, September 6, 2023

Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.
  • Crestwood Equity Partners LP (NYSE: CEQP ), relating to its proposed sale to Energy Transfer LP.
  • Under the terms of the agreement, CEQP shareholders will receive 2.07 shares of Energy Transfer per share they own.
  • Under the terms of the agreement, CTG shareholders will receive $10.50 in cash per share they own.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – HCCI, HEP, CTG, CEQP

Retrieved on: 
Monday, August 28, 2023

Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, HCCI shareholders are expected to receive $45.50 in cash per share they own.
  • Holly Energy Partners, L.P. (NYSE: HEP ), relating to its proposed sale to HF Sinclair Corp.
  • Crestwood Equity Partners LP (NYSE: CEQP ), relating to its proposed sale to Energy Transfer LP.
  • Under the terms of the agreement, CEQP shareholders will receive 2.07 shares of Energy Transfer per share they own.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – SCU, NLTX, HCCI, CCF

Retrieved on: 
Tuesday, July 25, 2023

Under the terms of the agreement, Class A SCU shareholders are expected to receive $11.15 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, Class A SCU shareholders are expected to receive $11.15 in cash per share they own.
  • Under the terms of the agreement, NLTX shareholders are expected to own approximately 16% of the combined company.
  • Chase Corp. (NYSE: CCF ), relating to its proposed sale to an affiliate of investment funds managed by KKR.
  • Under the terms of the agreement, CCF shareholders are expected to receive $127.50 in cash per share they own.

HCCI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Heritage-Crystal Clean, Inc. to J.F. Lehman

Retrieved on: 
Monday, July 24, 2023

MONSEY, N.Y., July 24, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the $45.50 per share in cash pursuant to which Heritage-Crystal Clean, Inc. (Nasdaq: HCCI) (“HCCI”) has agreed to be sold to J.F.

Key Points: 
  • MONSEY, N.Y., July 24, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the $45.50 per share in cash pursuant to which Heritage-Crystal Clean, Inc. (Nasdaq: HCCI) (“HCCI”) has agreed to be sold to J.F.
  • On July 19, 2023, after the markets closed, HCCI announced that it had agreed to be sold to J.F.
  • Lehman for $45.50 per share in cash, a small 8.5% premium to the closing price on July 19, 2023.
  • “We are investigating whether the HCCI Board of Directors acted in the best interests of HCCI shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter.

Lifshitz Law PLLC Announces Investigations of HCCI, PRDS, NLTX, CCF

Retrieved on: 
Sunday, July 23, 2023

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of HCCI to an investment affiliate of J.F.

Key Points: 
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of HCCI to an investment affiliate of J.F.
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of NLTX and Neurogene Inc.
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of CCF to an affiliate of investment funds managed by KKR for $127.50 per share in cash for each share of CCF common stock owned.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

US Cities with high health care costs in 2021 spent 3 times more per person than cities with lower costs

Retrieved on: 
Thursday, July 6, 2023

WASHINGTON, July 6, 2023 /PRNewswire/ -- Median per person health care spending in the US exceeded $6,000 in 2021 and fluctuated across 183 local metropolitan areas, according to the most recent Healthy Marketplace Index from the Health Care Cost Institute. Local areas varied both in how many services patients used and the prices of those services. In metro areas with the highest use, patients used nearly three times more health care services than the lowest use metro areas. Prices in the most expensive metro area were more than double the prices in the least expensive area.

Key Points: 
  • In metro areas with the highest use, patients used nearly three times more health care services than the lowest use metro areas.
  • "High and growing health spending is forcing families, employers, and governments across the country to make difficult tradeoffs," said Health Care Cost Institute President and CEO Katie Martin.
  • "The Healthy Marketplace Index shows that health care costs depend a great deal on where you live, the result of market dynamics like prices, practice patterns, and competition.
  • From 2017 – 2021, median per person health care spending in the US increased by 24%.

This Week in Health News: 12 Stories You Need to See

Retrieved on: 
Friday, April 21, 2023

NEW YORK, April 21, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • The HCCUR examines year-over-year and 5-year cumulative trends in health care spending for individuals with employer-sponsored insurance, segmented by health care service category.
  • Could Fixing a Problem with the Heart Be Good for Your Brain?
  • In addition to these popular releases, several must-read earnings reports crossed the wire this week, including the quarterly results for Abbott and INVO Bioscience .
  • Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines , for media news roundups, writing tips, upcoming events, and more.